Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutamate receptor ionotropic, delta-2 subunit (GRID2) is a member of the ionotropic glutamate receptor family, predominantly expressed in cerebellar Purkinje cells, where it is essential for synapse formation, synaptic plasticity, and motor coordination[1][2][3]. Unlike typical ionotropic glutamate receptors, GRID2 is an orphan receptor that does not directly respond to glutamate but can interact with glycine and D-serine, though channel gating requires the presence of additional synaptic proteins (cerebellin-1 and neurexin-1β)[1][2][3]. Dysfunction or mutation of GRID2 leads to neurodevelopmental disorders, especially forms of cerebellar ataxia, and the receptor has a key (but indirect) role in maintaining normal cerebellar circuitry and motor function. Structural and pharmacological studies confirm its role as a cation-selective ion channel within the subfamily of delta-type ionotropic glutamate receptors, but its pharmacology remains poorly explored, with no current clinical drugs specifically targeting GRID2[1][2][3].
Antagonism of delta-2-containing ionotropic glutamate receptors (for the compounds above; however, pharmacological targeting in clinical use is unestablished)
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutamate receptor ionotropic, delta-2 subunit (GRID2).